Okereke Olivia I, Lyness Jeffrey M, Lotrich Francis E, Reynolds Charles F
Channing Division of Network Medicine (OIO), Department of Medicine, and Department of Psychiatry (OIO), Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States; Department of Psychiatry (JML), University of Rochester School of Medicine & Dentistry, Rochester, NY, United States; University of Pittsburgh Medical Center (FEL), Pittsburgh, PA, United States; Department of Psychiatry (CFR), University of Pittsburgh School of Medicine, and Department of Behavioral and Community Health Sciences (CFR), Graduate School of Public Health, Pittsburgh, PA, United States.
Focus (Am Psychiatr Publ). 2013 Winter;11(1):22-31. doi: 10.1176/appi.focus.11.1.22.
Depression is a leading cause of disease burden, disability and distress for millions of older adults. Thus, prevention of late-life depression is a priority research area. This article addresses the science of late-life depression prevention with the following: 1) an introduction to the Institute of Medicine framework of universal, selective and indicated prevention as it pertains to late-life depression, with particular attention to successes of indicated and selective prevention in primary care; 2) a discussion of how biomarkers can be integrated into prevention research, using interferon-alpha-induced depression as a model; 3) an outline for expansion of prevention to non-specialist care delivery systems in Low and Middle Income Countries - thus, extending the reach of current successful approaches; 4) a description of a novel approach to simultaneous testing of universal, selective and indicated prevention in late-life depression, with emphasis on study design features required to achieve practical, scalable tests of health impact.
抑郁症是数百万老年人疾病负担、残疾和痛苦的主要原因。因此,预防老年期抑郁症是一个优先研究领域。本文通过以下内容探讨老年期抑郁症的预防科学:1)介绍医学研究所关于普遍、选择性和针对性预防的框架,该框架与老年期抑郁症相关,尤其关注在初级保健中针对性和选择性预防的成功案例;2)以α-干扰素诱导的抑郁症为模型,讨论生物标志物如何整合到预防研究中;3)概述如何将预防扩展到低收入和中等收入国家的非专科护理提供系统,从而扩大当前成功方法的覆盖范围;4)描述一种在老年期抑郁症中同时测试普遍、选择性和针对性预防的新方法,重点强调实现对健康影响进行实用、可扩展测试所需的研究设计特点。